0001447362-21-000148.txt : 20210617
0001447362-21-000148.hdr.sgml : 20210617
20210617173625
ACCESSION NUMBER: 0001447362-21-000148
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stokes Frank
CENTRAL INDEX KEY: 0001782815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38984
FILM NUMBER: 211026038
MAIL ADDRESS:
STREET 1: C/O CASTLE BIOSCIENCES
STREET 2: 820 S. FRIENDSWOOD DRIVE, SUITE 201
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC
CENTRAL INDEX KEY: 0001447362
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770701774
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 S FRIENDSWOOD DRIVE
STREET 2: SUITE 401
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
BUSINESS PHONE: 866-788-9007
MAIL ADDRESS:
STREET 1: 505 S FRIENDSWOOD DRIVE
STREET 2: SUITE 401
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
4
1
wf-form4_162396576996441.xml
FORM 4
X0306
4
2021-06-15
0
0001447362
CASTLE BIOSCIENCES INC
CSTL
0001782815
Stokes Frank
C/O CASTLE BIOSCIENCES, INC.
505 S. FRIENDSWOOD DRIVE, SUITE 401
FRIENDSWOOD
TX
77546
0
1
0
0
Chief Financial Officer
Common Stock
2021-06-15
4
M
0
11600
2.39
A
17520
D
Common Stock
2021-06-15
4
S
0
11600
73.02
D
5920
D
Common Stock
2021-06-16
4
M
0
2127
2.39
A
8047
D
Common Stock
2021-06-16
4
S
0
2127
73.07
D
5920
D
Common Stock
2021-06-17
4
M
0
1273
2.39
A
7193
D
Common Stock
2021-06-17
4
S
0
1273
73
D
5920
D
Stock option (right to buy)
2.39
2021-06-15
4
M
0
11600
0
D
2028-05-09
Common Stock
11600.0
28537
D
Stock option (right to buy)
2.39
2021-06-16
4
M
0
2127
0
D
2028-05-09
Common Stock
2127.0
26410
D
Stock option (right to buy)
2.39
2021-06-17
4
M
0
1273
0
D
2028-05-09
Common Stock
1273.0
25137
D
These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 14, 2021.
Includes 2,034 shares acquired on February 26, 2021 under the Issuer's employee stock purchase plan.
This transaction was executed in multiple trades at prices ranging from $73.00 to $73.13, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $73.00 to $73.33, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option is exercisable immediately, in whole or in part, conditioned upon the Reporting Person entering into a restricted stock purchase agreement with respect to any unvested shares. 25% of the 133,137 shares originally subject to the option vested on December 4, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.
/s/ Greg Acosta, Attorney-in-fact
2021-06-17